Ultimate Health Tech Trends to Watch in 2026
Explore the ultimate health tech trends of 2026, including agentic AI and cybersecurity, that are transforming patient care and experiences.
157 articles in this category
Explore the ultimate health tech trends of 2026, including agentic AI and cybersecurity, that are transforming patient care and experiences.
Explore the transformative impact of AI in clinical trials, focusing on costs, asset treatment, and expert insights for sponsors and CROs.
Explore 10 essential insights on AI in healthcare, focusing on how Hexaware and CareInsight are transforming patient care and operational efficiency.
Discover 10 essential ways AI in healthcare is revolutionizing medical services in Africa, backed by a $50 million initiative from the Gates Foundation and OpenAI.
Explore how the mobile pulse rate monitor is transforming cardiac care in Scotland, enhancing patient outcomes and reducing wait times.
A judge has temporarily blocked the Trump administration's attempt to rescind health grants from Democratic-led states, impacting vital public health funding.
Explore the EPA climate change findings and their critical implications for public health, including air quality and disease transmission risks.
Discover the ultimate advancements in men's health developments for 2025, including non-hormonal contraceptives and AI in urology.
Explore the ultimate transformations in personalized digital healthcare by Hims & Hers, leveraging innovative technology for patient-focused solutions.
St. Joseph's Health is revolutionizing cardiac care with AI heart detection technology, transforming patient outcomes and preventative healthcare strategies through advanced machine learning algorithms.
Omega Healthcare demonstrates excellence in AI-driven healthcare solutions, earning an impressive 97.8 overall performance score and five A+ grades in the latest KLAS First Look Report.
BioMarin Pharmaceutical faces a challenging Q4 earnings report with projected year-over-year profit decline despite anticipated revenue increases, raising questions about operational efficiency in the rare disease treatment sector.